Når primær leverkreft er assosiert med ascites, gulsott, fjernmetastaser, etc., kalles det avansert primær leverkreft. Behandlingen av avansert primær leverkreft er vanskelig, og den kliniske behandlingseffekten er ikke ideell. Kirurgi er ikke et alternativ for behandling av avansert leverkreft fordi den har spredt seg til lymfeknuter eller andre organer.
If the liver is in good condition (Child-Pugh grade A or B), the doctor will consider treatment with the targeted therapeutic drugs Sorafenib (Nexavar) or Lenvama (Lenvima). Growth can prolong the survival time of patients. If the patient develops drug resistance, the targeted drug repaglinide (Stivarga) or the immunterapi drug nivolumab (Opdivo) can be used instead.
In addition, keeping an eye on clinical trial information at any time and actively participating in relevant clinical trials such as chemotherapy, radiotherapy, and immunotherapy may also bring opportunities and hope for patients with advanced leverkreft. It is hoped that in the next few years, researchers will make a huge breakthrough in the field of liver cancer diagnosis and treatment.
